Related Experiment Video

Updated: Mar 28, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K

Deficiencies in the Management of Iron Deficiency Anemia During Childhood

Jacquelyn M Powers1,2, Catherine L Daniel3, Timothy L McCavit1,2

  • 1Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas.

Pediatric Blood & Cancer
|January 6, 2016
PubMed

Insights

Managing iron deficiency anemia (IDA) in children requires improvement. This study found issues with iron dosing, adherence, and follow-up, highlighting a need for better pediatric anemia care.

Area of Science:

  • Pediatric Hematology
  • Anemia Management
  • Clinical Quality Improvement

Background:

  • High-quality evidence for managing iron deficiency anemia (IDA) is limited.
  • Pediatric IDA presents unique challenges in diagnosis and treatment.
  • Institutional performance assessment is crucial for improving patient outcomes.

Purpose of the Study:

  • To retrospectively review institutional practices for managing pediatric iron deficiency anemia.
  • To identify areas for improvement in IDA treatment protocols.
  • To evaluate the effectiveness of current IDA management strategies in a pediatric population.

Main Methods:

  • Retrospective chart review of 195 consecutive pediatric patients with IDA.
  • Analysis of patient demographics, etiology of IDA, treatment protocols, and adherence.
  • Evaluation of referral patterns and iron dosage administration.

Main Results:

  • The majority of patients were young children (≤4 years, 64%) with nutritional IDA (74%).
  • Adolescents (11-18 years, 31%) frequently had IDA secondary to menorrhagia (42%).
  • Common issues included inappropriate iron dosing, poor medication adherence, and high rates of loss to follow-up.

Conclusions:

  • Significant improvements are needed in the management of pediatric iron deficiency anemia.
  • Optimizing iron dosing, enhancing medication adherence, and improving patient follow-up are critical.
  • Standardizing IDA treatment protocols can lead to better outcomes in children.

Keywords:
adolescentinfantiron deficiency anemiamanagement

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.7K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

1.0K

Related Concept Videos

Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
59
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
372
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.8K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702